PRSS3 and cancer: Importantly, ourresults indicate that suomilide inhibits the invasion of prostatecancer cells, making it an attractive lead molecule for the developmentof a drug targeting cancers associated with high trypsin-3 activity.This information should facilitate the identification of aeruginosinvariants, which may facilitate future drug development studies aimingto develop even more selective trypsin-3 inhibitors.